Background The long-term trajectories of estimated glomerular filtration rate (eGFR) and their relation to early proteinuria ...

Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...

In a multicenter, phase 2 trial across 31 centers in 10 countries, apecotrep (BI 764198) reduced proteinuria by 40% over 12 ...

Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with prima ...

We expect underlying revenue growth in 2026 to be similar to last year. We also anticipate continued margin expansion and ...

Good day and thank you for joining us for Cavco Industries' fourth quarter and fiscal year 2025 earnings conference call. During this call, you'll be hearing from Bill Boor, President and Chief ...

Get Government & Politics updates in your inbox! Stay up-to-date on the latest in local and national government and political topics with our newsletter.

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

Climate change poses significant economic, social, political and environmental challenges, with impacts more effective on dry areas. This research presents an analysis o ...

Youxin Technology Ltd (Nasdaq: YAAS) (the "Company" or "Youxin Technology"), a software as a service ("SaaS") and platform ...

Cold air is firmly in control for the week ahead, with plenty of sunshine but very little warmth to go around. Gusty winds early on will make it feel even colder, especially the next couple of days, ...